Abstract: The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.
| # | Name | Date |
|---|---|---|
| 1 | 202517058963-STATEMENT OF UNDERTAKING (FORM 3) [19-06-2025(online)].pdf | 2025-06-19 |
| 2 | 202517058963-REQUEST FOR EXAMINATION (FORM-18) [19-06-2025(online)].pdf | 2025-06-19 |
| 3 | 202517058963-PRIORITY DOCUMENTS [19-06-2025(online)].pdf | 2025-06-19 |
| 4 | 202517058963-POWER OF AUTHORITY [19-06-2025(online)].pdf | 2025-06-19 |
| 5 | 202517058963-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [19-06-2025(online)].pdf | 2025-06-19 |
| 6 | 202517058963-FORM 18 [19-06-2025(online)].pdf | 2025-06-19 |
| 7 | 202517058963-FORM 1 [19-06-2025(online)].pdf | 2025-06-19 |
| 8 | 202517058963-DECLARATION OF INVENTORSHIP (FORM 5) [19-06-2025(online)].pdf | 2025-06-19 |
| 9 | 202517058963-COMPLETE SPECIFICATION [19-06-2025(online)].pdf | 2025-06-19 |
| 10 | 202517058963-RELEVANT DOCUMENTS [19-09-2025(online)].pdf | 2025-09-19 |
| 11 | 202517058963-FORM-26 [19-09-2025(online)].pdf | 2025-09-19 |
| 12 | 202517058963-FORM 13 [19-09-2025(online)].pdf | 2025-09-19 |
| 13 | 202517058963-Retyped Pages under Rule 14(1) [16-10-2025(online)].pdf | 2025-10-16 |
| 14 | 202517058963-2. Marked Copy under Rule 14(2) [16-10-2025(online)].pdf | 2025-10-16 |
| 15 | 202517058963-Proof of Right [10-11-2025(online)].pdf | 2025-11-10 |